Synergistic and additive killing by antimicrobial factors found in human airway surface liquid

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 5 23-5, 2000, Pages

  Singh, Pradeep K ^a   Tack, Brian F ^a   McCray Jr , Paul B ^a   Welsh, Michael J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cystic fibrosis; Innate immunity; Lactoferrin; Lysozyme; defensins

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; HUMAN BETA DEFENSIN 1; HUMAN BETA DEFENSIN 2; LACTOFERRIN; LYSOZYME; PEPTIDE DERIVATIVE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TOBRAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; CYSTIC FIBROSIS; HUMAN; INFECTION RESISTANCE; IONIC STRENGTH; LUNG FLUID; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0033725250     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.5.l799     Document Type: Article

References (34)

1. Antimicrobial synergism in the therapy of gram-negative rod bacteremia
2. Ion composition and rheology of airway liquid from cystic fibrosis fetal tracheal xenografts
3. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
4. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
5. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis
6. Innate antimicrobial activity of nasal secretions
7. Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens
8. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
9. The fractional inhibitory concentration (FIC) index as a measure of synergy
10. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease
11. Antimicrobial defensin peptides of the human ocular surface
12. Elemental content of airway surface liquid from infants with cystic fibrosis
13. Elemental composition of human airway surface fluid in healthy and diseased airways
14. Human nasal respiratory secretions and host defense
15. Significance of antimicrobial synergism for the outcome of gram negative sepsis
16. Ion composition of airway surface liquid of patients with cystic fibrosis compared with normal and disease-control subjects
17. Antimicrobial combinations
18. Distribution of secretory leukoprotease inhibitor in the human nasal airway
19. Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands
20. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease
21. Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity
22. Integrated host defense against infections
23. Bacteriostatic effect of human milk on Escherichia coli: The role of IgA
24. The separation and characterization of proteins intrinsic to nasal secretion
25. Production of β-defensins by human airway epithelia
26. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
27. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis
28. Long-term tobacco smoking and mucociliary clearance from the human lung in health and respiratory impairment
29. Activity of abundant antimicrobials of the human airway
30. Human β-defensin-1: An antimicrobial peptide of urogenital tissues
31. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia
32. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro
33. p15s (15-kD antimicrobial proteins) are stored in the secondary granules of Rabbit granulocytes: Implications for antibacterial synergy with the bactericidal/permeability-increasing protein in inflammatory fluids
34. Airway surface fluid volume and Cl content in cystic fibrosis and normal bronchial xenografts